Pages

Showing posts with label ADVICE. Show all posts
Showing posts with label ADVICE. Show all posts

NJ BALANCED ADVANTAGE FUND - NFO

 

INCESTMENT INDIA

NJ Balanced Advantage Fund is an open-ended Dynamic Asset allocation fund. This fund is suitable for those investors who are looking for Long Term Capital Growth & Dynamic asset allocation between equity and specified debt securities.

A new fund is being offered. It will open on October 8, 2021 and close on October 22, 2021.

Plans / Options:

  • Regular Plan
  • Direct Plan
Each Plan Offers the following two Options.
  • Growth Option &
  • Payout of Income Distribution cum Capital withdrawal Option (IDCW)  

Upcoming flexi cap fund - NJ FLEXI CAP FUND.

Face value: Rs.10/-

Benchmark: Nifty 50 Hybrid Composite Debt 50:50 Index

Minimum Application Amount: 500/- Rs. and multiples of 1/- Rs. thereof.

Exit Load:

If redeemed or switched out within 30 days of allotment, the exit load will be charged at 1% for the first 30 days, then it will be zero.

Transaction Charges:

  • First time investor in a Mutual Fund, the distributor may be paid Rs.150/- as transaction charge per subscription of  Rs.10000/- and above.
  • For existing investors in a Mutual Fund, the distributor may be paid Rs.100/- as transaction charge per subscription of Rs. 10000/- and above.
  • In case of SIP's the transaction charge shall be applicable only if the total commitment through SIP's amount to Rs. 10000/- and above. In such cases, the transaction charge shall be recovered in 3-4 instalments.

Overview of SBI Retirement Benefit Fund

Levy of Stamp Duty on applicable on Mutual Fund Transaction will be 0.005%.

NJ Balance Advantage fund nfo asset allocation details.

Instruments

Indicative Allocations (% of total assets)

Risk Profile

 

Minimum

Maximum

High/Medium/Low

Equity & Equity related instruments including Derivatives

0%

100%

Medium to High

Specified Debt Securities

0%

100%

Low to Medium

 

  • The scheme may also invest in derivatives instruments to the extent of 50% of the net asset of the scheme. The scheme will not have a leveraged position in derivatives.  
  • The scheme will not invest in foreign securities, securitized debt and equity linked debentures.
  • The scheme will not invest in debt investments.

Where will the NJ Balanced Advantage fund invest?

  1. Equity related instruments include convertible debentures, convertible preference shares, warrants carrying the right to obtain equity shares, equity derivatives and such other instrument as may be specified by the Board from time to time.
  2. Equity Derivatives, which are financial instruments, generally traded on the stock exchange, the price of which is directly dependent upon the value of equity shares or equity indices. Derivative involve the trading of rights or obligations based on the underlying, but do not directly transfer property.
  3. TREPS, Repo / Reverse (in Government securities), Treasury bills, cash and cash equivalents.
  4. Government securities issued by central, state governments and other securities issued by RBI from time to time.

Top 5 Advantages of Equity SIP.

Who manages the fund?

Mr. Rishi Sharma. (B.Com, PGDBA)

Minimum Target Amount: Rs.10 Cr.

Annual Scheme Recurring Expenses:

  • Investment Management and Advisory Fee up to 2.25%.
  • Additional expenses up to 0.05%.
  • Additional expenses for gross new inflows form specified cities up to 0.30%.

Sponsor of the Fund: NJ India Invest Private Limited.







Exxaro Tiles Ltd IPO: Apply or Not?

On January 2, 2008, 'Ricasil Ceramic Pvt Ltd' was incorporated in Himmatnagar as' Ricasil Ceramic Pvt Ltd. ' On December 9, 2020, a General Meeting was conducted. The company's name was changed to its current name, 'Exxaro Tiles Limited.'

Production Specifications: Double Charge Verified Tiles and Glazed Vitrified Tiles are produced by the business. At the moment, the company primarily offers products in 6 sizes and 1000+ designs. Exxaro Tiles Ltd. has two cutting-edge production plants in Gujarat, Padra and Talod, with a combined installation capacity of 1,32,00,000 sq. mt. p.a. Unit II is one of the largest plants for manufacturing glazed verified tiles under one roof in India. (Source: Brickwork Report) 

Network of the Company: Currently, over 2000 registered dealers supply products for large-scale infrastructure projects. The company has grown its operations to 27 states and 12 countries, including Poland, Italy, and Bosnia.

Revenue from Exports: For fiscal years 2021, 2020, and 2019, the company's revenue from exports contributed 13.88%, 13.51%, and 6.68%, respectively, of all its revenue operations.

Strengths of the Company:

  1. Modern production facilities with a significant emphasis on design and quality.
  2. Widespread sales and dealers network
  3. A large product portfolio with around 1000 designs
Financials of The Company:

Particulars

for the year/period ended (₹ in million)

31-03-2021

31-03-2020

31-03-2019

Total Assets

3693.14

3870.55

3582.55

Total Revenue

2598.53

2439.64

2440.06

Profit After Tax

152.23

112.59

89.17

IPO Details:

IPO Opening Date

04-08-2021

IPO Closing Date

06-08-2021

Face Value

10₹. Per Equity Share

or the year/period ended (₹ in million)IPO Price


₹118 to ₹120 per equity share

 

Market Lot

125 Shares

Listing At

BSE, NSE

Issue Size

161.09 Cr.


IPO Time Table:

IPO Open Date

04-08-2021       

IPO Close Date

06-08-2021

Allotment Date

11-08-2021

Listing Date

17-08-2021


Recommendation
Apply for only listing gain


(Source:- All details are collected from sebi website)

Should we apply for Devyani International IPO? - check this.


Devyani International Limited is the largest   franchisee of Yum Brands in India.   Founded  in 1991, they are among the   largest operators of chain quick-service     restaurants in India. The company operates   665 stores across 155cities in India, as of   March 31, 2021.

 Overview of the Company

Devyani International Limited first   collaborated with Yum in 1997, when it opened a Pizza Hut location in Jaipur. Following that, they extended their business by acquiring KFC and Pizza Hut franchisees. As of March 31, 2021, the business operated 264 KFC restaurants, 297 Pizza Hut restaurants, and 44 Costa Coffee locations throughout India.

The company's operations are divided into three business verticals.

1. KFC, Pizza Hut, and Costa Coffee are examples of core brands.

2. International expansion — KFC and Pizza Hut locations in Nepal and Nigeria.

3. Other businesses — Own-brand stores such as Vaango and Food Street in the F & B industry.

Strengths of the Company

1. A portfolio of well-known worldwide brands.

2. A multi-dimensional, all-inclusive QSR player.

3. Presence in major consuming markets using a cluster-based strategy.

4. Cross-brand synergies through operational leverage.

5. A distinguished Board of Directors and an experienced senior management team.

Strategy of the Company

1. Continue to improve unit-level performance by strategically expanding the Brand Business retail network.

2. Invest in technology and emphasize digital capabilities.

Company Financial

Particulars

For the Year ended (Rs. In a million)

31-03-2021

31-03-2020

31-03-2019

Total Assets

16684.07

18835.76

18074.90

Total Revenue

11988.95

15350.41

13236.83

Profit After Tax

-813.24

-787.52

-592.90






IPO Details

Ipo Opening Date

04-08-2021

Ipo Closing Date

06-08-2021

IPO Price

Rs. 86 to Rs.90 per Equity Share

Market Lot

165 Shares

Issue Size

Equity Share of Rs.1 (aggregating up to Rs.1838.00 Cr)

IPO Time Table

Opening Date

04-08-2021

Closing Date

06-08-2021

Allotment Date

11-08-2021

Listing Date

16-08-2021

I do not recommend this IPO because the company has been making losses for a long time.

Windlas Biotech Limited - IPO details


The company was incorporated as 'Windlas Biotech Limited' on February 19, 2001. The Company is one of the leading in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry in India in terms of revenue. With over two decades of experience in manufacturing both solid and liquid pharmaceutical dosage form and significant experience in providing specialized capabilities, including, high potency, controlled substances and low-solubilify. Windlas Biotech provides a comprehensive range of  CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics.

Market Share:- In 2020 Windlas Biotech Limited's market share was approximately 1.5% in terms of revenue in the domestic formulations CDMO industry.

Sales Process:- The company also sell their own branded products in the trade generics and OTC market as well as export generic products to several countries.  

Current Focus:- Windlas Biotech Limited currently focus on launching new complex generic products in chronic therapeutic category linked in to lifestyle related disorders.

Business Verticals:- The Company has three distinct strategic business verticals.

  1. CDMO Service and Products
  2. Domestic Trade Generics and over-the-counter Brands
  3. Exports
All verticals are supported by a network of R&D laboratories and manufacturing facilities which in turn are supported by various functions, including supply chain, inventory, finance and human resources.

Company Strengths:-
  1. Leading CDMO in India with a focus on the chronic therapeutic category.
  2. Innovative Portfolio of complex generic products supported by robust R&D Capabilities.
  3. Efficient and quality compliant manufacturing facilities with significant entry barriers.
  4. Strong and long-term relationships with leading Indian pharmaceutical Companies
  5. Consistent track record of financial performance
  6. Experienced Professional and Technical Qualified Management Team
Financial Reports:-

Particulars

                                        Years (amt in Millions)   

31-12-2020

31-03-2020

31-03-2019

Total Assets

3158.83

3384.88

2981.80

Total Revenue

3230.94

3313.39

3565.76

Profit After Tax

96.74

162.13

638.22

 
IPO Details:-

IPO Opening Date

4/08/2021

IPO Closing Date

06/08/2021

Face Value

5 Rs. Per Equity Share

IPO Price

Rs. 448 to Rs.460 per Share

Market Lot

30 Shares

Listing At

BSE, NSE

Issue Size

401.54 Cr


IPO Table:-

IPO Open Date

04/08/2021

IPO Close Date

06/08/2021

Allotment Date

11/08/2021

Listing Date

17/08/2021

  
IPO Lot Size:-

minimum 1 lot (30 shares, amt 13800 Rs.) maximum 14 lots (420 Shares, amt 193200Rs.)

Our Suggestion 

Recommended for short term

Rolex Rolled Rings IPO Details with Grey Market Premium.


 Company History:-

Rolex Rolled Rings started as a partnership in 1977-78 under the name Rolex Industries, and was later converted into a joint stock company under the Companies Act 1951, with the name Rolex Rings Pvt Ltd and a certificate of incorporation dated February 13, 2003.

Business Overview:-

The company produces hot rolled forged and machine bearing rings, as well as automotive components for vehicle segments such as two-wheelers, passenger vehicles, commercial vehicles, off-highway vehicles, electric vehicles, industrial machines, wind turbines, and railways. The Company domestically and internationally to large marquee customers, including some leading bearing manufacturing companies. The Company has 22 forging lines with a combined installed capacity of 1,44,750 M.T.P.A., Machining facility with 528 spindles and a total install capacity of 69 million components per year.

Company Strength:-

  1. One of the Top 5 Forging Company.
  2. Strong Manufacturing Capacity
  3. Good business background History.
  4. Export in 19 Countries since long time with healthy relation
  5. Continue financial growth
Financial Details of Company:-

Particulars

                                                            Years     (amt in a million)

31-03-2021

31-03-2020

31-03-2019

Total Assets

7969.24

6861.73

7822.57

Total Revenue

6197.57

6753.32

9112.54

Profit After Tax

869.55

529.41

590.51

 IPO Details:-                                                                  

IPO Opening Date

28-07-2021

IPO Closing Date

30-07-2021

Face Value

10 Rs. Per Equity Share

IPO Price

880 Rs. To 990 Rs.

Market Lot

16 Shares

Listing At

BSE, NSE

Issue Size

731 CR.

IPO Time Table:-

IPO Open Date

28-07-2021

IPO Close Date

30-07-2021

Allotment Date

04-08-2021

Listing Date

09-08-2021

IPO Lot Size:

minimum lot size 1 (16 shares =14400Rs.) & maximum lot size 13 (208 shares = 187200Rs.)

Grey Market Premium:-

Grey market premium as on 27-07-2021 is 450 Rs. per share.

Our Suggestion:-

Recommended.

Canara Robeco Manufacturing Fund - NFO

 Canara Robeco Manufacturing Fund- NFO Canara Robeco is come with new open-ended equity oriented Thematic Fund based on Manufacturing theme....